BAXTER INTERNATIONAL INC

Baxter International Inc. provides essential healthcare products and therapies across three primary operating segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. Its portfolio includes sterile intravenous solutions, infusion systems, parenteral nutrition therapies, surgical sealants and equipment, smart beds, patient monitoring systems, respiratory health devices, specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. These products serve diverse healthcare providers, including hospitals, nursing homes, rehabilitation centers, ambulatory surgical facilities, doctor offices, dialysis centers, and home-care patients.

The company manufactures products in more than 20 countries and sells to healthcare providers in over 100 countries worldwide. Baxter maintains international commercial operations spanning Europe, the Middle East, Africa, Asia-Pacific, Latin America, and Canada, while employing approximately 37,500 people globally across its domestic and foreign locations. In addition, the organization maintains research and development facilities in Belgium, India, Italy, Malta, and the United States, and conducts corporate operations from its headquarters in Deerfield, Illinois.

Summary of the business section of Baxter International's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

“As of December 31, 2025, after giving effect to the Kidney Care sale, we employed approximately 37,500 people globally, with approximately 15,100 employees in the United States and approximately 22,400 employees outside of the United States.”